Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

TriVascular Technologies gives FY 2014 revenue guidance in line with analysts' estimates


Wednesday, 14 May 2014 04:01pm EDT 

TriVascular Technologies:Expects FY 2014 revenue to be in the range of $32.0 million to $36.0 million.FY 2014 revenue of $33 million - Thomson Reuters I/B/E/S. 

Company Quote

5.42
-0.03 -0.55%
2 Jul 2015